Laxmi Dental Ltd

Laxmi Dental Limited announced its unaudited consolidated financial results for Q2 and H1 FY27. The company reported its highest-ever quarterly revenue of ₹795.2 million (up 10.0% YoY) and EBITDA of ₹152.7 million (up 38.5% YoY) for Q2 FY27. For H1 FY27, revenue grew 11.9% YoY to ₹1,542.2 million, and EBITDA increased 29.2% YoY to ₹296.3 million. PAT after share of JVs for Q2 FY27 was ₹100.4 million, a 17.6% YoY increase. The company plans to deploy unutilised IPO proceeds, including ₹26.9 crore towards a company-owned integrated dental laboratory and aligner facility, to enhance efficiency and scalability. Management highlighted a positive outlook for India's dental industry, driven by digitalization and increasing demand for quality products.

Laxmi Dental Limited announced that its Board of Directors, in a meeting held on November 03, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026 (Q2/H1FY26-27). The results, which are consolidated and standalone, were accompanied by a limited review report from the statutory auditors. The financial statements will be available on the company's website.

Laxmi Dental Limited announced the approval of its un-audited financial results for the quarter and half-year ended September 30, 2026 (Q2/H1FY26-27). The Board of Directors met on November 03, 2026, to consider and approve both consolidated and standalone financial statements. The company also provided the Limited Review Report from its statutory auditors. The results will be available on the company's website. The filing also detailed the company's subsidiaries and joint ventures, including Bizdent Devices Private Limited, Signature Smile Dental Clinic Private Limited, Rich Smile Design LLP, Laxmi Dental Lab USA INC., Diverse Dental Lab INC., KIDS-E-Dental LLP, and IDBG Al Dent Global Private Limited.

Laxmi Dental Ltd has announced that its Board of Directors will convene on November 3, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company also informed that the trading window for designated persons will reopen 48 hours after the results are declared. The financial results will be available on the company's website.

Laxmi Dental Ltd's subsidiary, Laxmi Dental Lab USA, INC, has received a tariff refund of US$ 0.63 million (approximately INR 59.20 million) from U.S. Customs and Border Protection. This refund is a result of the US Supreme Court's directive to refund excess tariffs collected from importers. The company will also make this information available on its website.

Laxmi Dental Ltd has announced the incorporation of Leelaben Foundation, a company limited by guarantee and registered as a Section 8 company under the Companies Act, 2013. The Foundation was incorporated on October 21, 2026, with its registered office in Mumbai, Maharashtra. The Ministry of Corporate Affairs issued the Certificate of Incorporation and the licence under Section 8(1) of the Companies Act, 2013, on the same date. This marks a significant step in the company's commitment to its social or charitable objectives.

Laxmi Dental Ltd has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations. ICRA Limited, the monitoring agency, has confirmed that the utilization of Initial Public Offer (IPO) proceeds is in line with the objects of the issue, with no material deviation. The report covers the utilization of the Gross Proceeds of INR 138.000 Crore from the IPO, which opened on January 13, 2025, and closed on January 15, 2025. Shareholder approval for any changes in fund deployment was obtained at the 22nd AGM held on September 25, 2026.

Laxmi Dental Ltd announced that its Board of Directors, in a meeting held on October 08, 2026, approved the company becoming a member of Leelaben Foundation. Leelaben Foundation is a proposed company limited by guarantee, to be incorporated as a Section 8 Company under the Companies Act, 2013. The foundation's objectives are focused on social welfare, including establishing rural dental facilities, providing subsidized and free dental treatment, and utilizing CSR channels for contributions and awareness. The Board also addressed a delay in compliance with SEBI Listing Regulations for the quarter ended June 30, 2026, attributing it to a procedural oversight. The company has paid the fine levied by the exchanges.

Laxmi Dental Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the quarter and half-year ended September 30, 2026. The closure applies to all designated persons and their immediate relatives, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The date for the Board of Directors' meeting to approve these financial results will be communicated separately.

Laxmi Dental Ltd has received approval from both the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for the listing of 7,911 equity shares. These shares are being issued under the Laxmi Dental Employee Stock Option Scheme 2024. The approvals signify the completion of the ESOP allotment process and allow for the trading of these new shares on both exchanges, effective September 18, 2026. This move is part of the company's strategy to incentivize and retain its employees through equity-based compensation.